chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Decreased appetite, Fatigue, Feeling jittery, Flushing
Clinical narrative: No appetite; congested head; congested head, cough; headache; fatigue; nausea; about an hour after flush, increased heart rate, very jittery - able to continue to work but unpleasant; about an hour after flush, increased heart rate, very jittery - able to continue to work but unpleasant; about an hour after flush, increased heart rate, very jittery - able to continue to work but unpleasant; This is a spontaneous report from a contactable other health care professional. A 43-year-old female patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 18Dec2020 11:00 at single dose at arm (pending clarification) for COVID-19 immunization. Medical history included asthma, allergies, depression, penicillin allergy, allergies to: Mangoes, Cashews, Peaches. Concomitant medications included sertraline hydrochloride (ZOLOFT), montelukast sodium (SINGULAIR), fexofenadine hydrochloride (ALLEGRA), fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]). The patient previously took amoxicillin and experienced known allergies: Amoxicillin. On 18Dec2020: about an hour after flush, increased heart rate, very jittery - able to continue to work but unpleasant. Lasted about an hour. On 19Dec2020: afternoon - headache, nausea, fatigue started. On 20Dec2020: continued to feel fatigued and same symptoms. On 21Dec2020: headache, waves of nausea along with feeling flush (no fever ever) and elevated heart rate. On 22Dec2020: Same. The patient continued to work through all this but felt lousy. On 23Dec2020: stayed home from work because work wanted the patient to take a Covid Test (this was negative) - so laid around. Still with headache and nausea, easily fatigued. Cough started PM. On 24Dec2020: no nausea but continued headache, congested head, cough. On 25Dec2020: feeling better. No appetite. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been tested for COVID-19, and was negative on 23Dec2020. The outcome of the events was recovered. The patient did not receive treatment for the events.   Information about lot/batch number has been requested.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate, Heart rate increased, Nausea, SARS-CoV-2 test
Clinical narrative: No appetite; congested head; congested head, cough; headache; fatigue; nausea; about an hour after flush, increased heart rate, very jittery - able to continue to work but unpleasant; about an hour after flush, increased heart rate, very jittery - able to continue to work but unpleasant; about an hour after flush, increased heart rate, very jittery - able to continue to work but unpleasant; This is a spontaneous report from a contactable other health care professional. A 43-year-old female patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 18Dec2020 11:00 at single dose at arm (pending clarification) for COVID-19 immunization. Medical history included asthma, allergies, depression, penicillin allergy, allergies to: Mangoes, Cashews, Peaches. Concomitant medications included sertraline hydrochloride (ZOLOFT), montelukast sodium (SINGULAIR), fexofenadine hydrochloride (ALLEGRA), fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]). The patient previously took amoxicillin and experienced known allergies: Amoxicillin. On 18Dec2020: about an hour after flush, increased heart rate, very jittery - able to continue to work but unpleasant. Lasted about an hour. On 19Dec2020: afternoon - headache, nausea, fatigue started. On 20Dec2020: continued to feel fatigued and same symptoms. On 21Dec2020: headache, waves of nausea along with feeling flush (no fever ever) and elevated heart rate. On 22Dec2020: Same. The patient continued to work through all this but felt lousy. On 23Dec2020: stayed home from work because work wanted the patient to take a Covid Test (this was negative) - so laid around. Still with headache and nausea, easily fatigued. Cough started PM. On 24Dec2020: no nausea but continued headache, congested head, cough. On 25Dec2020: feeling better. No appetite. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been tested for COVID-19, and was negative on 23Dec2020. The outcome of the events was recovered. The patient did not receive treatment for the events.   Information about lot/batch number has been requested.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Upper respiratory tract congestion
Clinical narrative: No appetite; congested head; congested head, cough; headache; fatigue; nausea; about an hour after flush, increased heart rate, very jittery - able to continue to work but unpleasant; about an hour after flush, increased heart rate, very jittery - able to continue to work but unpleasant; about an hour after flush, increased heart rate, very jittery - able to continue to work but unpleasant; This is a spontaneous report from a contactable other health care professional. A 43-year-old female patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 18Dec2020 11:00 at single dose at arm (pending clarification) for COVID-19 immunization. Medical history included asthma, allergies, depression, penicillin allergy, allergies to: Mangoes, Cashews, Peaches. Concomitant medications included sertraline hydrochloride (ZOLOFT), montelukast sodium (SINGULAIR), fexofenadine hydrochloride (ALLEGRA), fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]). The patient previously took amoxicillin and experienced known allergies: Amoxicillin. On 18Dec2020: about an hour after flush, increased heart rate, very jittery - able to continue to work but unpleasant. Lasted about an hour. On 19Dec2020: afternoon - headache, nausea, fatigue started. On 20Dec2020: continued to feel fatigued and same symptoms. On 21Dec2020: headache, waves of nausea along with feeling flush (no fever ever) and elevated heart rate. On 22Dec2020: Same. The patient continued to work through all this but felt lousy. On 23Dec2020: stayed home from work because work wanted the patient to take a Covid Test (this was negative) - so laid around. Still with headache and nausea, easily fatigued. Cough started PM. On 24Dec2020: no nausea but continued headache, congested head, cough. On 25Dec2020: feeling better. No appetite. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been tested for COVID-19, and was negative on 23Dec2020. The outcome of the events was recovered. The patient did not receive treatment for the events.   Information about lot/batch number has been requested.
Sex: M
Vaccine: HPV9
Symptoms: Crohn's disease
Clinical narrative: Chron's disease; This spontaneous report was received from a physician referring to a 16 years old male patient. The patient's pertinent medical history, concomitant drugs and drug allergies were reported as unknown.  On 29-JUN-2018, the patient was vaccinated with his first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, dose, anatomical location, route, lot number and expiration date were not reported) for prophylaxis. And on 31-JAN-2019, he received the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9).    On 30-JUN-2019, the patient was admitted to the hospital and on an unknown in 2019, he was diagnosed with Chron's disease. The outcome of Chron's disease was unknown. It was unknown if he received any treatment. It was unknown if the patient had sought medical attention or if any lab diagnostics/studies were performed. The outcome of crohn's disease was unknown.  The causality between Chron's disease and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not provided.  Upon internal review, Chron's disease was determined to be medically significant.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity, Rash
Clinical narrative: allergic reaction, diffuse rash, no utricaria; no respiratory symptoms.   Rash developed 2 days after vaccination.   Treated with antihystamines.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Body temperature, Computerised tomogram, Migraine, Pain
Clinical narrative: Fever of 101 Chills; body aches; ocular migraine; abdominal cramping and pain; This is a spontaneous report received from a contactable Pharmacist. A female patient of unspecified age (reported as "44 without unit") received the 1st dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ett9899) via Intramuscular on 18Dec2020 13: 00 at single dose in the arm left for COVID-19 immunisation. Medical history was none. Concomitant medications included claritin, OCP. The patient previously took cephalosporin and experienced allergy. The patient experienced Fever of 101 Chills, body aches, ocular migraine, then developed abdominal cramping and pain at 18Dec2020 19:00. Symptoms lasted 3 days and then completely resolved. Adverse events result in emergency room/department or urgent care. The patient received treatment for events and underwent lab tests, which included CT of Head. Outcome of events was recovered on 22Dec2020.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever of 101 Chills; body aches; ocular migraine; abdominal cramping and pain; This is a spontaneous report received from a contactable Pharmacist. A female patient of unspecified age (reported as "44 without unit") received the 1st dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ett9899) via Intramuscular on 18Dec2020 13: 00 at single dose in the arm left for COVID-19 immunisation. Medical history was none. Concomitant medications included claritin, OCP. The patient previously took cephalosporin and experienced allergy. The patient experienced Fever of 101 Chills, body aches, ocular migraine, then developed abdominal cramping and pain at 18Dec2020 19:00. Symptoms lasted 3 days and then completely resolved. Adverse events result in emergency room/department or urgent care. The patient received treatment for events and underwent lab tests, which included CT of Head. Outcome of events was recovered on 22Dec2020.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Blood pressure increased, Dysgeusia, Dyspnoea, Feeling hot
Clinical narrative: I had an anaphalytic reaction where my air way began to swell within about 15-20 minutes after the injection.  I got flushed and hot.      About 30 minutes in I was given 50mg benedryl by mouth and had to inject my Epi-Pen after about 40 minutes but the symptoms didnt subside so I was sent to the ER. I was given an additional 120 IV solumedrol, 30 mg more of benedryl and it was so severe it was difficult to breathe and talk. My BP remained elevated but normalized before I was dischaged with 40mg of prednisone by mouth for 5 days.  8hrs after the shot when I got home my throat began to feel tight again so I took more benedryl at that time.  I had a very strong metallic taste in my mouth within an hour after the vaccination which lingered for several days.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Pharyngeal swelling, Speech disorder, Throat tightness
Clinical narrative: I had an anaphalytic reaction where my air way began to swell within about 15-20 minutes after the injection.  I got flushed and hot.      About 30 minutes in I was given 50mg benedryl by mouth and had to inject my Epi-Pen after about 40 minutes but the symptoms didnt subside so I was sent to the ER. I was given an additional 120 IV solumedrol, 30 mg more of benedryl and it was so severe it was difficult to breathe and talk. My BP remained elevated but normalized before I was dischaged with 40mg of prednisone by mouth for 5 days.  8hrs after the shot when I got home my throat began to feel tight again so I took more benedryl at that time.  I had a very strong metallic taste in my mouth within an hour after the vaccination which lingered for several days.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness, Fatigue, Glassy eyes
Clinical narrative: My eyes were glassy; Lightheadedness and dizziness; Fatigue; Low-grade temperature of 99.0 F with chills; Low-grade temperature of 99.0 F with chills; This is a spontaneous report from a contactable nurse (patient herself).  This 25-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL0140), via intramuscular, on 23Dec2020 at 13:45 at single dose for COVID-19 immunisation Vaccine location was left arm. The patient was not pregnant. The patient was vaccinated at hospital, age at vaccination was 25-year-old. Relevant medical history included ongoing irritable bowel syndrome, ongoing allergies tree nuts and peanuts. Past drug history included allergy to penicillin. Relevant concomitant medications included famotidine, sertraline, and ethinylestradiol, ferrous fumarate, norethisterone acetate (JUNEL FE) for birth control. No other vaccine was received in four weeks At approximately 16:00 on 23Dec2020, she had sudden onset of fatigue, a low-grade temperature of 99.0 F with chills. By 17:30, she was also bringing to experience lightheadedness and dizziness. That night at approximately 22:00, she had temperature of 99.1. On 24Dec2020, she experienced lightheadedness and dizziness the entire day, from waking up to going to bed later that night. Her eyes were glassy and she would feel an impulse of dizziness go distinctly from the right side of her head to the left, and then felt more dizzy after that. It was constant throughout the entire day and would occur while she was sitting, standing, or moving around. On 25Dec2020, she was tired but the dizziness had gone away. Pre-vaccination and post-vaccination COVID tests were not performed. No therapeutic measures were taken as result of the events. The patient had recovered from the events in Dec2020.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: My eyes were glassy; Lightheadedness and dizziness; Fatigue; Low-grade temperature of 99.0 F with chills; Low-grade temperature of 99.0 F with chills; This is a spontaneous report from a contactable nurse (patient herself).  This 25-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL0140), via intramuscular, on 23Dec2020 at 13:45 at single dose for COVID-19 immunisation Vaccine location was left arm. The patient was not pregnant. The patient was vaccinated at hospital, age at vaccination was 25-year-old. Relevant medical history included ongoing irritable bowel syndrome, ongoing allergies tree nuts and peanuts. Past drug history included allergy to penicillin. Relevant concomitant medications included famotidine, sertraline, and ethinylestradiol, ferrous fumarate, norethisterone acetate (JUNEL FE) for birth control. No other vaccine was received in four weeks At approximately 16:00 on 23Dec2020, she had sudden onset of fatigue, a low-grade temperature of 99.0 F with chills. By 17:30, she was also bringing to experience lightheadedness and dizziness. That night at approximately 22:00, she had temperature of 99.1. On 24Dec2020, she experienced lightheadedness and dizziness the entire day, from waking up to going to bed later that night. Her eyes were glassy and she would feel an impulse of dizziness go distinctly from the right side of her head to the left, and then felt more dizzy after that. It was constant throughout the entire day and would occur while she was sitting, standing, or moving around. On 25Dec2020, she was tired but the dizziness had gone away. Pre-vaccination and post-vaccination COVID tests were not performed. No therapeutic measures were taken as result of the events. The patient had recovered from the events in Dec2020.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Urticaria
Clinical narrative: raised bumps/hives all over body; Generalized Rash that is itchy; This is a spontaneous report from a contactable nurse (patient). A 34-year-old female patient received their first dose of BNT162B2 (lot number: ER5730; expiration date unknown), via an unspecified route of administration on the right arm on 20Dec2020 at 11:30 at single dose for COVID-19 immunization. Medical history was not reported. Concomitant medication included amoxicillin. The patient experienced Generalized Rash that is itchy, raised bumps/hives all over body on 27Dec2020. Therapeutic measures were taken as a result of the events which included treatment with hydroxyzine. The patient did not recover from the events.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Burning sensation
Clinical narrative: I felt as if I had blow torches during the 2 hour mark on the lateral thighs, femur bone pain and hip pain.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angioedema, Periorbital oedema, Periorbital swelling, Rash, Swelling
Clinical narrative: Angioedema; This is a spontaneous report from a contactable Other Health Professional (patient). A 40-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EL1284, intramuscular in the right arm (also reported as right shoulder), first dose on 22Dec2020 00:30 at a single dose for Covid-19 immunization. The patient's relevant medical history included severe reaction to some animal dander and pollen, severe reactions to poison oak, possible drug induced reactions (unspecified) post C-section, mild rash with influenza vaccine this year (2020) (with no other hx of adverse reaction to a vaccine); had allergies to pollen, mold, some animals. The patient previously took influenza vaccine (split virion, inactivated) and experienced rash. The patient had no covid prior vaccination nor was she tested post vaccination. Adverse event reported was angioedema on 24Dec2020 with outcome of recovering. Systems started appearing on 23Dec2020 evening with slight rash and fluid collection under right eye. Developed more rash on 24Dec2020. In the evening to early morning of 25Dec2020, symptoms worsened significantly. Rapid swelling to face occurred. Swelling was concentrated around eyes and cheeks the most. Both right and left side of the face and neck were affected. However, the right side face had a more pronounced reaction. MD ordered oral prednisone and Benadryl as treatment plan. Also, ordered episode-pen for a worst case scenario. Symptoms have been improving under treatment but still persist some. The events were reported as non-serious. The adverse event start date was 24Dec2020 (as reported). The event resulted in doctor or other healthcare professional office/clinic visit.; Sender's Comments: There is a reasonable possibility that the event angioedema was related to BNT162b2 based on known drug safety profile and temporal relationship.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling face
Clinical narrative: Angioedema; This is a spontaneous report from a contactable Other Health Professional (patient). A 40-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EL1284, intramuscular in the right arm (also reported as right shoulder), first dose on 22Dec2020 00:30 at a single dose for Covid-19 immunization. The patient's relevant medical history included severe reaction to some animal dander and pollen, severe reactions to poison oak, possible drug induced reactions (unspecified) post C-section, mild rash with influenza vaccine this year (2020) (with no other hx of adverse reaction to a vaccine); had allergies to pollen, mold, some animals. The patient previously took influenza vaccine (split virion, inactivated) and experienced rash. The patient had no covid prior vaccination nor was she tested post vaccination. Adverse event reported was angioedema on 24Dec2020 with outcome of recovering. Systems started appearing on 23Dec2020 evening with slight rash and fluid collection under right eye. Developed more rash on 24Dec2020. In the evening to early morning of 25Dec2020, symptoms worsened significantly. Rapid swelling to face occurred. Swelling was concentrated around eyes and cheeks the most. Both right and left side of the face and neck were affected. However, the right side face had a more pronounced reaction. MD ordered oral prednisone and Benadryl as treatment plan. Also, ordered episode-pen for a worst case scenario. Symptoms have been improving under treatment but still persist some. The events were reported as non-serious. The adverse event start date was 24Dec2020 (as reported). The event resulted in doctor or other healthcare professional office/clinic visit.; Sender's Comments: There is a reasonable possibility that the event angioedema was related to BNT162b2 based on known drug safety profile and temporal relationship.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angioedema, Asthma, Blister, Facial discomfort, Urticaria
Clinical narrative: Angioedema; This is a spontaneous report from a contactable Other Health Professional (patient). A 40-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EL1284, intramuscular in the right arm (also reported as right shoulder), first dose on 22Dec2020 00:30 at a single dose for Covid-19 immunization. The patient's relevant medical history included severe reaction to some animal dander and pollen, severe reactions to poison oak, possible drug induced reactions (unspecified) post C-section, mild rash with influenza vaccine this year (2020) (with no other hx of adverse reaction to a vaccine); had allergies to pollen, mold, some animals. The patient previously took influenza vaccine (split virion, inactivated) and experienced rash. The patient had no covid prior vaccination nor was she tested post vaccination. Adverse event reported was angioedema on 24Dec2020 with outcome of recovering. Systems started appearing on 23Dec2020 evening with slight rash and fluid collection under right eye. Developed more rash on 24Dec2020. In the evening to early morning of 25Dec2020, symptoms worsened significantly. Rapid swelling to face occurred. Swelling was concentrated around eyes and cheeks the most. Both right and left side of the face and neck were affected. However, the right side face had a more pronounced reaction. MD ordered oral prednisone and Benadryl as treatment plan. Also, ordered episode-pen for a worst case scenario. Symptoms have been improving under treatment but still persist some. The events were reported as non-serious. The adverse event start date was 24Dec2020 (as reported). The event resulted in doctor or other healthcare professional office/clinic visit.; Sender's Comments: There is a reasonable possibility that the event angioedema was related to BNT162b2 based on known drug safety profile and temporal relationship.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: single hive on abdomen (itchy)/full body hives and itching; single hive on abdomen (itchy)/full body hives and itching; This is a spontaneous report from a contactable Physician. A 36-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EL0140, expiry date unknown) intramuscular at left arm on 24Dec2020 at single dose for Covid-19 immunization in a hospital facility. Medical history included Anxiety, Hypertension, and GERD (gastrooesophageal reflux disease). The patient was not diagnosed with Covid-19 prior to vaccination. Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP) on 08Dec2020 for immunization; bupropion hydrochloride (WELLBUTRIN), amlodipine, omeprazole; from unspecified date for unspecified indication. On 25Dec2020, the patient developed a single hive on abdomen (itchy), and on 26Dec2020 the patient developed full body hives and itching but spared the face and mucosal surfaces. The patient has no swelling, no respiratory symptoms. The patient has not been tested for Covid-19 since the vaccination. The patient received treatment of antihistamines (steroids if no improvement) on unspecified date. The hives responded to antihistamines temporarily. The outcome of the event single hive on abdomen (itchy)/full body hives and itching was not recovered. The reporter considered the events non-serious; did not results in death, was not life threatening, did not caused/prolonged hospitalization, was not disabling/incapacitating, not a congenital anomaly/birth defect.; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event hives and itching due to temporal association.
Sex: F
Vaccine: PPV
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: allergic reaction from the PNEUMOV AX 23 vaccine; entire upper left arm is swollen 3 times the size; pain.; This spontaneous report was received from a 67-year-old female patient who was reporting on herself. The patient's medical history and concomitant therapies were reported as "no". She was allergic to latex and many unspecified antibiotics. She was vaccinated with pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (PREVENAR) last year and never had any issues with it.   On 28-DEC-2020, the patient was vaccinated with dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection into left arm (dose, lot number, expiration date, route of administration and strength were not provided) as prevention for pneumonia.  On 28-DEC-2020, few hours after vaccination with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), the allergic reaction occurred. Her upper left arm was swollen 3 times the size, she also was experiencing pain. The patient reported that the pain was 10 on 1 to 10 scale. She sought medical attention and contacted her doctor. Her physician informed her to use ice and acetaminophen (TYLENOL) for pain and swelling. The patient still did not recover from the mentioned events. She wants to know how long it would take to recover from the reaction.  The reporter considered all events to be related to with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23).
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Nausea, Vomiting
Clinical narrative: Vomiting; chills; Diarrhea; Nausea; fatigue; This is a spontaneous report from a contactable nurse(patient). A 34-year-old female patient received first dose BNT162B2 (lot number: EL0140), via an unspecified route of administration on 28Dec2020 07:00 at 34 years old at single dose at Left arm for COVID-19 immunization.  Medical history included Migraines, asthma, chronic bronchitis, PCOS, Allergies to Penicillin. The concomitant medications were biotin, bifidobacterium infantis, lactobacillus acidophilus(PROBIOTIC), Multivitamin, vitex agnus castus. The patient previously took codeine and experienced allergies. Nausea and fatigue beginning about four hours after administration on 28Dec2020 11:00. Diarrhea beginning about six hours after administration on 28Dec2020 13:00. Vomiting and chills beginning about eight hours after administration on 28Dec2020 15:00. There was no treatment received for the adverse event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was Recovering.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tachycardia
Clinical narrative: Developed tachycardia around 12:55 pm; This is a spontaneous report from a contactable other HCP (Patient). A 48-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EH9899) via an unspecified route of administration in left arm on 28Dec2020 07:55 at single dose for COVID-19 immunization. Medical history included asthma, GERD, vestibular migraines, Penicillin allergy.  Concomitant medication included famotidine (PEPCID), ergocalciferol (VITAMIN D), magnesium, multivitamin. The patient previously took Relafen and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had the vaccine around 28Dec2020 7:55 am. Developed tachycardia around 28Dec2020 12:55 pm and EMS was called. She was evaluated at the ER on 28Dec2020 and 29Dec2020. Saw cardiologist on 29Dec2020. Currently wearing Holter monitor and will need ECHO. AE resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No treatment was received for the adverse event. Event outcome was not recovered.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood potassium decreased, Decreased appetite, Dizziness, Dyspnoea, Echocardiogram
Clinical narrative: Developed tachycardia around 12:55 pm; This is a spontaneous report from a contactable other HCP (Patient). A 48-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EH9899) via an unspecified route of administration in left arm on 28Dec2020 07:55 at single dose for COVID-19 immunization. Medical history included asthma, GERD, vestibular migraines, Penicillin allergy.  Concomitant medication included famotidine (PEPCID), ergocalciferol (VITAMIN D), magnesium, multivitamin. The patient previously took Relafen and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had the vaccine around 28Dec2020 7:55 am. Developed tachycardia around 28Dec2020 12:55 pm and EMS was called. She was evaluated at the ER on 28Dec2020 and 29Dec2020. Saw cardiologist on 29Dec2020. Currently wearing Holter monitor and will need ECHO. AE resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No treatment was received for the adverse event. Event outcome was not recovered.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Electrocardiogram ambulatory, Fatigue, Heart rate increased, Incomplete course of vaccination
Clinical narrative: Developed tachycardia around 12:55 pm; This is a spontaneous report from a contactable other HCP (Patient). A 48-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EH9899) via an unspecified route of administration in left arm on 28Dec2020 07:55 at single dose for COVID-19 immunization. Medical history included asthma, GERD, vestibular migraines, Penicillin allergy.  Concomitant medication included famotidine (PEPCID), ergocalciferol (VITAMIN D), magnesium, multivitamin. The patient previously took Relafen and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had the vaccine around 28Dec2020 7:55 am. Developed tachycardia around 28Dec2020 12:55 pm and EMS was called. She was evaluated at the ER on 28Dec2020 and 29Dec2020. Saw cardiologist on 29Dec2020. Currently wearing Holter monitor and will need ECHO. AE resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No treatment was received for the adverse event. Event outcome was not recovered.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Muscle twitching, Myalgia, Nausea, Oxygen saturation decreased
Clinical narrative: Developed tachycardia around 12:55 pm; This is a spontaneous report from a contactable other HCP (Patient). A 48-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EH9899) via an unspecified route of administration in left arm on 28Dec2020 07:55 at single dose for COVID-19 immunization. Medical history included asthma, GERD, vestibular migraines, Penicillin allergy.  Concomitant medication included famotidine (PEPCID), ergocalciferol (VITAMIN D), magnesium, multivitamin. The patient previously took Relafen and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had the vaccine around 28Dec2020 7:55 am. Developed tachycardia around 28Dec2020 12:55 pm and EMS was called. She was evaluated at the ER on 28Dec2020 and 29Dec2020. Saw cardiologist on 29Dec2020. Currently wearing Holter monitor and will need ECHO. AE resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No treatment was received for the adverse event. Event outcome was not recovered.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations, SARS-CoV-2 test negative, Tachycardia
Clinical narrative: Developed tachycardia around 12:55 pm; This is a spontaneous report from a contactable other HCP (Patient). A 48-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EH9899) via an unspecified route of administration in left arm on 28Dec2020 07:55 at single dose for COVID-19 immunization. Medical history included asthma, GERD, vestibular migraines, Penicillin allergy.  Concomitant medication included famotidine (PEPCID), ergocalciferol (VITAMIN D), magnesium, multivitamin. The patient previously took Relafen and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had the vaccine around 28Dec2020 7:55 am. Developed tachycardia around 28Dec2020 12:55 pm and EMS was called. She was evaluated at the ER on 28Dec2020 and 29Dec2020. Saw cardiologist on 29Dec2020. Currently wearing Holter monitor and will need ECHO. AE resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No treatment was received for the adverse event. Event outcome was not recovered.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure abnormal, Cough, Pyrexia, Throat irritation
Clinical narrative: She received the Moderna vaccine on 12/28. She then started to feel some itching in her throat within 5 minutes. It then started to get worse and then she started to cough.  Vital signs show blood pressure 152/89 with pulse 72 oxygen saturation 100% with respiratory to 16. She was given liquid Benadryl and the coughing and itchiness in her throat lasted for three hours. She went to sleep as the Benadryl caused her to be drowsy. When she awoke she had no symptoms. She then had a fever later in the day.  she had no hives, lip swelling, tongue swelling, shortness of breath or presyncope associated with these symptoms.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Hypertension, Tachycardia
Clinical narrative: Patient came to our vaccination clinic to receive the COVID-19 vaccine and test. Administration was provided by LVN and patient was directed to our post-vaccination observation area to wait the 15 minutes. During those 15 minutes the patient became symptomatic and per the NP was having tachycardia, chest tightness and hypertension symptoms. NP made the decision to call EMS. EMS arrived at approximately 1515 and triaged patient, EMS then transported the patient to the ED. Husband was called and went with patient to the ED. Husband was escorted by security to ED.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arrhythmia, Back pain, Chest discomfort, Diarrhoea, Dizziness
Clinical narrative: Patient came to our vaccination clinic to receive the COVID-19 vaccine and test. Administration was provided by LVN and patient was directed to our post-vaccination observation area to wait the 15 minutes. During those 15 minutes the patient became symptomatic and per the NP was having tachycardia, chest tightness and hypertension symptoms. NP made the decision to call EMS. EMS arrived at approximately 1515 and triaged patient, EMS then transported the patient to the ED. Husband was called and went with patient to the ED. Husband was escorted by security to ED.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dry mouth, Erythema, Fatigue, Headache, Hypertension
Clinical narrative: Patient came to our vaccination clinic to receive the COVID-19 vaccine and test. Administration was provided by LVN and patient was directed to our post-vaccination observation area to wait the 15 minutes. During those 15 minutes the patient became symptomatic and per the NP was having tachycardia, chest tightness and hypertension symptoms. NP made the decision to call EMS. EMS arrived at approximately 1515 and triaged patient, EMS then transported the patient to the ED. Husband was called and went with patient to the ED. Husband was escorted by security to ED.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain, Paraesthesia oral, Tachycardia
Clinical narrative: Patient came to our vaccination clinic to receive the COVID-19 vaccine and test. Administration was provided by LVN and patient was directed to our post-vaccination observation area to wait the 15 minutes. During those 15 minutes the patient became symptomatic and per the NP was having tachycardia, chest tightness and hypertension symptoms. NP made the decision to call EMS. EMS arrived at approximately 1515 and triaged patient, EMS then transported the patient to the ED. Husband was called and went with patient to the ED. Husband was escorted by security to ED.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Musculoskeletal stiffness, Neck injury, Neck pain, Pain
Clinical narrative: stiffness; Spreading from my shoulder up my neck to the base of my skull/worsening pain; Limited ROM; Horrific pain upon turning my neck towards the left; Woke up the following morning with a kink in my left neck; This is a spontaneous report from a contactable nurse, the patient.  A 44-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ECT1685), via an unspecified route of administration in the left arm on 23Dec2020 at 13:15 (at the age of 44-years-old) as a single dose for COVID-19 immunization.  Medical history included anxiety, depression, hypothyroidism, lumbar fusion, and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included sertraline hydrochloride (ZOLOFT), colecalciferol (VIT D3), and alprazolam (XANAX). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Dec2020 at 09:00, the patient woke up the following morning with a kink in her left neck, which was similar to sleeping awkwardly. She applied some heat and took some ibuprofen (ADVIL). It persisted on 25Dec2020 and she did the same treatment. On 26Dec2020, the pain was exponentially worse and spreading from her shoulder up her neck to the base of her skull. She had limited range of motion. She had horrific pain upon turning her neck towards the left. She went to the emergency room on 27Dec2020 and 28Dec2020 due to the worsening pain, stiffness, and loss of function. The patient was treated with ibuprofen and unspecified muscle relaxers. The patient had not been tested for COVID-19 post vaccination. The clinical outcomes of the kink in her neck, neck pain, limited range of motion, worsening pain, and stiffness, were not recovered. The events were all reported as non-serious.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Hyperhidrosis, Nausea, Nightmare
Clinical narrative: Nausea; Vomiting; Diarrhea; Bad dreams; Extreme chills; Heavy amount of sweating; This is a spontaneous report from a contactable other HCP (patient). A 26-year-old male patient received the first dose of BNT162B2 (lot number: EK5730), via an unspecified route of administration in left arm, on 24Dec2020  09:30 AM at single dose for COVID-19 immunization. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient was not tested for COVID-19. Allergies to medications, food, or other products included Bactrim. Relevant medical history included Kyphosis, Binge Eating Disorder, Anxiety, Depression, ADHD, Obesity, Hypertension, all ongoing. No other vaccines were received within 4 weeks prior to the COVID vaccine. The medications received within 2 weeks of vaccination included omeprazole(PROTONIX), Lisinopril, HCTZ, Atenolol, vilazodone hydrochloride(VIIBRYD). The patient experienced Nausea, Vomiting, Diarrhea, Bad dreams, Extreme chills, Heavy amount of sweating, Elevated motivation to work/be productive, Very optimistic on 28Dec2020 01:00 PM. No treatment was received for the events. The outcome of the events was not recovered.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Nausea; Vomiting; Diarrhea; Bad dreams; Extreme chills; Heavy amount of sweating; This is a spontaneous report from a contactable other HCP (patient). A 26-year-old male patient received the first dose of BNT162B2 (lot number: EK5730), via an unspecified route of administration in left arm, on 24Dec2020  09:30 AM at single dose for COVID-19 immunization. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient was not tested for COVID-19. Allergies to medications, food, or other products included Bactrim. Relevant medical history included Kyphosis, Binge Eating Disorder, Anxiety, Depression, ADHD, Obesity, Hypertension, all ongoing. No other vaccines were received within 4 weeks prior to the COVID vaccine. The medications received within 2 weeks of vaccination included omeprazole(PROTONIX), Lisinopril, HCTZ, Atenolol, vilazodone hydrochloride(VIIBRYD). The patient experienced Nausea, Vomiting, Diarrhea, Bad dreams, Extreme chills, Heavy amount of sweating, Elevated motivation to work/be productive, Very optimistic on 28Dec2020 01:00 PM. No treatment was received for the events. The outcome of the events was not recovered.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Throat tightness
Clinical narrative: acute anaphylactic reaction to the Covid-19 Pfizer vaccine/throat was closing (laryngeal edema); This is a spontaneous report from a contactable consumer (patient herself).  A 58-year-old female received bnt162b2 (BNT162B2 also reported as COVID 19 vaccine brand Pfizer, lot EJ1685, expiry date not reported), via an unspecified route of administration on the right arm on 24Dec2020 07:30 at single dose (dose 1) for Covid 19 immunisation. Medical history included gout and severe allergy to seafoods. Concomitant medication included influenza vaccine on Dec2020 (received within 4 weeks prior to the COVID vaccine). The patient was not diagnosed with COVID-19 and was not been tested for COVID-19. The patient informed that she experienced an acute anaphylactic reaction on 24Dec2020 09:15 characterized by throat was closing (laryngeal edema) which was the same type of reaction that she experienced when exposed to seafood. She was sent to Emergency room/department or urgent care and was given liquid Benadryl and Prednisone 40mg as treatment. The outcome of event was recovered.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Cold sweat, Headache, Palpitations
Clinical narrative: Patient presented to receive COVID-19 vaccine (Pfizer) at approximately 1621. Patient waited 15 minutes when asking to leave was asked if she had any symptoms, patient reported headache. NP asked patient to lay down in stretcher and took repeat vitals which showed elevated BP. Patient reported feeling clammy had palpitations. NP made decision to call EMS. EMS arrived and transported patient to ED at 1735.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Feeling cold, Headache, Palpitations
Clinical narrative: 27 yo F presented to COVID vaccine clinic to receive vaccination. Post vaccine started having palpitations and headaches as well as chest tightness. Patient currently taking albuterol post covid infection. Pt recently diagnosed with COVID 12/13 with onset of symptoms on 12/11 discharged as of 12/22 and currently working. Last set of vitals prior to EMS arriving was 117/57 spo2 83. Patient reported feeling cold. Patient was provided with juice and cracker and transported to the ED via EMS.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Anxiety, Asthenia, Blood test normal, Discomfort
Clinical narrative: palpitations, tachycardia, dizziness and prurititic rash on upper chest several minutes after receiving her first dose of COVID vaccine. malaise ensuing over next few days, paresthesias in legs.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Ear discomfort, Feeding disorder, Feeling abnormal, Gait disturbance
Clinical narrative: palpitations, tachycardia, dizziness and prurititic rash on upper chest several minutes after receiving her first dose of COVID vaccine. malaise ensuing over next few days, paresthesias in legs.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Limb discomfort, Palpitations, Rash, Seizure
Clinical narrative: palpitations, tachycardia, dizziness and prurititic rash on upper chest several minutes after receiving her first dose of COVID vaccine. malaise ensuing over next few days, paresthesias in legs.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sleep deficit, Tremor, Vaginal haemorrhage
Clinical narrative: palpitations, tachycardia, dizziness and prurititic rash on upper chest several minutes after receiving her first dose of COVID vaccine. malaise ensuing over next few days, paresthesias in legs.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Malaise, Palpitations, Paraesthesia, Rash pruritic
Clinical narrative: palpitations, tachycardia, dizziness and prurititic rash on upper chest several minutes after receiving her first dose of COVID vaccine. malaise ensuing over next few days, paresthesias in legs.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tachycardia
Clinical narrative: palpitations, tachycardia, dizziness and prurititic rash on upper chest several minutes after receiving her first dose of COVID vaccine. malaise ensuing over next few days, paresthesias in legs.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Electrocardiogram, Electroencephalogram, Full blood count, Lipids
Clinical narrative: Loss of short term memory; This is a spontaneous report from a contactable other healthcare professional. A 64-year-old female patient receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: unknown), via an unspecified route of administration on 28Dec2020, 13:45 at single dose for an unspecified indication. Medical history included shrimp allergy from an unknown date. The patient's concomitant medications were not reported. The patient experienced loss of short term memory on 29Dec2020 15:45. No treatment was given for the event. Patient has no prior COVID vaccination. Patient was not tested for COVID post vaccination. Outcome of the event was not recovered. Events were reported as non-serious.